Skip to main content
Clinical Trials/NCT05862103
NCT05862103
Recruiting
Not Applicable

Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort - a Prospective, Multicenter Study

Yu Bo18 sites in 1 country15,000 target enrollmentDecember 21, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Yu Bo
Enrollment
15000
Locations
18
Primary Endpoint
Incidence of MACCE
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

AMI Survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.

Registry
clinicaltrials.gov
Start Date
December 21, 2022
End Date
December 30, 2026
Last Updated
8 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Yu Bo
Responsible Party
Sponsor Investigator
Principal Investigator

Yu Bo

Director

Harbin Medical University

Eligibility Criteria

Inclusion Criteria

  • AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit.
  • Telephone to obtain informed consent from the subjects/family members of the subjects.

Exclusion Criteria

  • Not available

Outcomes

Primary Outcomes

Incidence of MACCE

Time Frame: 5 years after discharge

the incidence of MACCE (death, heart failure, rehospitalization, re-myocardial infarction, re-myocardial revascularization, stroke, malignant arrhythmia, bleeding events, etc.) in AMI patients

Secondary Outcomes

  • Differences of MACCE between the optimized group and the non-optimized group(5 years after discharge)
  • Differences of the MACCE between OCT-guided group and the coronary angiography -guided group(5 years after discharge)
  • Differences of MACCE between defer PCI group and direct PCI group(3 and 5 years after discharge)
  • Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group(5 years after discharge)

Study Sites (18)

Loading locations...

Similar Trials